Molecular Formula | C23H23ClN2O4 |
Molar Mass | 426.89 |
Density | 1.31 |
Melting Point | 162.0-163.5 °C |
Boling Point | 586.7±50.0 °C(Predicted) |
Solubility | DMSO: >20mg/mL |
Appearance | solid |
Color | off-white |
pKa | -0.97±0.20(Predicted) |
Storage Condition | Sealed in dry,Store in freezer, under -20°C |
In vitro study | BML-190 the selectivity of CB2 receptor is 50 times higher than that of CB1 receptor. In HEK-293 cells stably expressing human CB2 receptors, BML-190 enhanced Forskolin-stimulated cAMP accumulation. BML-190 reduces basal levels of inositol phosphate production in cells expressing the CB2 receptor. 10 M BML-190 reduced 38% of the accumulation of inositol phospholipids. BML-190 is an aminoalkylindole. BML-190 can produce at least 15 metabolites. BML-190 reduced LPS-induced NO and IL-6 production in a concentration-dependent manner. BML-190 also inhibited LPS-induced PGE2 production and COX-2 sensing. |
WGK Germany | 3 |
biological activity | BML-190 (IMMA) is a selective reverse agonist of cannabinoid CB2 receptor, Ki is 435 nM, which is 50 times more selective than acting on CB1 receptor. |
target | TargetValue CB2 435 nM(Ki) |
Target | Value |
CB2 | 435 nM(Ki) |
in vitro studies | BML-190 are 50 times more selective for CB2 receptors than for CB1 receptors. In HEK-293 cells stably expressing the human CB2 receptor, the cAMP accumulation stimulated by the BML-190 was enhanced. BML-190 decrease the basal level of inositol phosphate production in cells expressing the CB2 receptor. 10 μM BML-190 reduce 38% inositol phospholipid accumulation. BML-190 is an aminoalkyl indole. BML-190 can produce at least 15 metabolites. BML-190 reduced LPS-induced NO and IL-6 production in a concentration-dependent manner. BML-190 also inhibited LPS-induced PGE2 production and COX-2 induction. |